These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 8790908

  • 1. The role of alpha 2-antiplasmin in the inhibition of clot lysis in newborns and adults.
    Ries M, Klinge J, Rauch R, Keuper H, Harms D.
    Biol Neonate; 1996; 69(5):298-306. PubMed ID: 8790908
    [Abstract] [Full Text] [Related]

  • 2. In vitro fibrinolysis after adding low doses of plasminogen activators and plasmin generation with and without oxidative inactivation of plasmin inhibitors in newborns and adults.
    Ries M, Klinge J, Rauch R, Trusen B, Zenker M, Keuper H, Harms D.
    J Pediatr Hematol Oncol; 1996 Nov; 18(4):346-51. PubMed ID: 8888740
    [Abstract] [Full Text] [Related]

  • 3. A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis.
    Schneider M, Nesheim M.
    J Biol Chem; 2004 Apr 02; 279(14):13333-9. PubMed ID: 14715655
    [Abstract] [Full Text] [Related]

  • 4. Regulation by alpha 2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma.
    Silence K, Collen D, Lijnen HR.
    Blood; 1993 Aug 15; 82(4):1175-83. PubMed ID: 7688990
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the murine plasma fibrinolytic system.
    Lijnen HR, van Hoef B, Beelen V, Collen D.
    Eur J Biochem; 1994 Sep 15; 224(3):863-71. PubMed ID: 7523120
    [Abstract] [Full Text] [Related]

  • 6. Whole blood clot lysis in newborns and adults after adding different concentrations of recombinant tissue plasminogen activator (Rt-PA).
    Trusen B, Ries M, Zenker M, Rauh M, Beinder E, Keuper H, Harms D.
    Semin Thromb Hemost; 1998 Sep 15; 24(6):599-604. PubMed ID: 10066156
    [Abstract] [Full Text] [Related]

  • 7. Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors.
    Walker JB, Bajzar L.
    J Thromb Haemost; 2007 Jun 15; 5(6):1257-64. PubMed ID: 17389009
    [Abstract] [Full Text] [Related]

  • 8. Age-related differences in a clot lysis assay after adding different plasminogen activators in a plasma milieu in vitro.
    Ries M, Zenker M, Klinge J, Keuper H, Harms D.
    J Pediatr Hematol Oncol; 1995 Aug 15; 17(3):260-4. PubMed ID: 7620925
    [Abstract] [Full Text] [Related]

  • 9. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
    Sugiyama N, Iwamoto M, Abiko Y.
    Thromb Res; 1987 Aug 15; 47(4):459-68. PubMed ID: 2821651
    [Abstract] [Full Text] [Related]

  • 10. Recombinant human C1-inhibitor prevents non-specific proteolysis by mutant pro-urokinase during optimal fibrinolysis.
    Gurewich V, Pannell R.
    Thromb Haemost; 2009 Aug 15; 102(2):279-86. PubMed ID: 19652878
    [Abstract] [Full Text] [Related]

  • 11. An analysis of mechanisms underlying the antifibrinolytic properties of radiographic contrast agents.
    Farrehi PM, Zhu Y, Fay WP.
    J Thromb Thrombolysis; 2001 Dec 15; 12(3):273-81. PubMed ID: 11981110
    [Abstract] [Full Text] [Related]

  • 12. Increased incorporation of antiplasmin into the fibrin network in patients with type 1 diabetes.
    Agren A, Jörneskog G, Elgue G, Henriksson P, Wallen H, Wiman B.
    Diabetes Care; 2014 Jul 15; 37(7):2007-14. PubMed ID: 24760258
    [Abstract] [Full Text] [Related]

  • 13. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ, Kluft C, Krug AH, Winkler U, Jespersen J, Gram JB.
    Thromb Haemost; 2017 Apr 03; 117(4):700-705. PubMed ID: 28150855
    [Abstract] [Full Text] [Related]

  • 14. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.
    Robbie LA, Booth NA, Croll AM, Bennett B.
    Thromb Haemost; 1993 Aug 02; 70(2):301-6. PubMed ID: 8236139
    [Abstract] [Full Text] [Related]

  • 15. Interaction between staphylokinase, plasmin(ogen), and alpha 2-antiplasmin. Recycling of staphylokinase after neutralization of the plasmin-staphylokinase complex by alpha 2-antiplasmin.
    Silence K, Collen D, Lijnen HR.
    J Biol Chem; 1993 May 05; 268(13):9811-6. PubMed ID: 7683664
    [Abstract] [Full Text] [Related]

  • 16. Role of alpha 2-antiplasmin in fibrin-specific clot lysis with single-chain urokinase-type plasminogen activator in human plasma.
    Declerck PJ, Lijnen HR, Verstreken M, Collen D.
    Thromb Haemost; 1991 Apr 08; 65(4):394-8. PubMed ID: 2057921
    [Abstract] [Full Text] [Related]

  • 17. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
    Wu JH, Diamond SL.
    J Clin Invest; 1995 Jun 08; 95(6):2483-90. PubMed ID: 7769094
    [Abstract] [Full Text] [Related]

  • 18. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.
    Sakata Y, Aoki N.
    J Clin Invest; 1982 Mar 08; 69(3):536-42. PubMed ID: 7199538
    [Abstract] [Full Text] [Related]

  • 19. Differences between neonates and adults in carbohydrate sequences and reaction kinetics of plasmin and alpha(2)-antiplasmin.
    Ries M, Easton RL, Longstaff C, Zenker M, Morris HR, Dell A, Gaffney PJ.
    Thromb Res; 2002 Feb 01; 105(3):247-56. PubMed ID: 11927131
    [Abstract] [Full Text] [Related]

  • 20. Effect of fibrin degradation products on fibrinolytic process.
    Yatsenko TA, Rybachuk VM, Yusova OI, Kharchenko SM, Grinenko TV.
    Ukr Biochem J; 2016 Feb 01; 88(2):16-24. PubMed ID: 29227597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.